Apollomics Inc. (APLM) stock
APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW
$17.68+0.38 (+2.20%)
Close on Nov 13, 2026Market cap $38.83MP/E –Yield –
Apollomics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Apollomics's enterprise value was $23.62M on Nov 11, 2026, against $13.26M a year earlier. Over the last 5 years it ranged from -$16.10M to $360.35B, with a median of $19.64M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $23.62M | +39.1% |
| 2025 | Dec 31, 2025 | $16.97M | – |
| 2024 | Dec 31, 2024 | -$15.17M | -787.4% |
| 2023 | Dec 29, 2023 | $2.21M | -100.0% |
| 2022 | Dec 30, 2022 | $29.07B | -91.9% |
| 2021 | Dec 31, 2021 | $358.82B | – |
See a number that looks wrong?